Literature DB >> 12174109

Pemphigoid nodularis (non-bullous): a clinicopathological study of five cases.

A M Powell1, S Albert, M J Gratian, R Bittencourt, B S Bhogal, M M Black.   

Abstract

Pemphigoid nodularis is a rare clinical variant of pemphigoid characterized by overlapping clinical features of both prurigo nodularis lesions and pemphigoid-like blisters. In pemphigoid nodularis, the immunopathological findings are identical to those of bullous pemphigoid (BP). We describe five patients who presented with the typical clinical phenotype of prurigo nodularis, who were found to have circulating and tissue-bound antibasement membrane zone autoantibodies. By immunoelectron microscopy and Western immunoblotting studies, the circulating antibodies were shown to target the hemidesmosome and specifically the BP antigens 1 and 2 (BP180 and BP230). In contrast to the majority of reported cases, none of these patients has ever developed blisters. The role of antibasement membrane zone antibodies in the development of the eruption, or the role of the eruption in the development and persistence of autoantibodies, is not clear. These cases demonstrate that the presence of these antibodies is not sufficient for the development of blisters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174109     DOI: 10.1046/j.1365-2133.2002.04754.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  [Bullous pemphigoid: first manifestation under a picture of prurigo simplex subacuta].

Authors:  N Hodzic-Avdagic; G Reinerth; J Reifenberger; R Kruse; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

3.  [Pemphigoid nodularis triggered by hypereosinophilic syndrome?].

Authors:  V von Felbert; D Simon; L Braathen; T Hunziker
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

4.  Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis.

Authors:  K T Amber; D Z Korta; S de Feraudy; S A Grando
Journal:  Clin Exp Dermatol       Date:  2017-06-09       Impact factor: 3.470

5.  Persistent Widespread Pruritic Nodules: A Quiz.

Authors:  Hong-Hao Hu; Wen-Jia Yang; Jiu-Hong Li; Hao Guo
Journal:  Acta Derm Venereol       Date:  2021-08-18       Impact factor: 3.875

6.  Juvenile pemphigoid nodularis: Report of a rare case.

Authors:  Dipti Das; Debabrata Bandyopadhyay
Journal:  Indian Dermatol Online J       Date:  2014-04

Review 7.  Case Report: Pemphigoid Nodularis-Five Patients With Many Years of Follow-Up and Review of the Literature.

Authors:  Konrad Szymanski; Alicja Adaszewska; Beata Jakubowska; Cezary Kowalewski; Ewelina Pietrzyk; Katarzyna Wozniak
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

8.  Severe pemphigoid nodularis successfully treated with dupilumab.

Authors:  Fatma Jendoubi; Chloe Bost; Emilie Tournier; Carle Paul; Maria Polina Konstantinou
Journal:  Dermatol Ther       Date:  2022-07-31       Impact factor: 3.858

Review 9.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.